Replies to post #4648 on Ariad Pharmaceuticals Inc fka ARIA

[JJM760]

Am I reading that right? They are saying $4.50 floor should Rida fail? That is the most bullish I have ever read from an analyst. You gotta love those projected number's! And that's with only $7/share for Pona.

[ariadndndough]

piggerpig thanks agian for posting that and rkrw yesterday from jefferies.

one thing that strikes me from both of these reports is how undervalued aria has been all along relativly compared to other biotechs mainly due to funding concerns. now that funding concerns have been cleared up wallstreet is waking up and seeing just how good aria pipeline is and the market is slowly adjusting to it.

these next few months will seem like years as we wait for the results.

goodluck everyone i am fully in.

dough

[BTH]

$17.50/share? Do you know how quick I would hit that bid?? LOL

Let's hope these monkeys are right. Sell-side analysts (especially biotechnology) are, IMO, the most overpaid clowns in the business.

Hoping this guy is right in this case.

Thanks for posting the research.

[iandy]

I've been projecting the share price to be around $6.50 when phase 3 Rida in Sarcoma results become known.
Should fail to meet the endpoints I expect us to end up with a 30% hit to the shares which would leave us at $4.55.

I pretty much agree with barclays.